Sitagliptin Hydrochloride
Antidiabetic Drug (Pyrazine-derivative)
Type 2 diabetes mellitus
Why Partner with Pinnacle Life Science
Regulatory Compliance
Manufactured under WHO-GMP compliant processes at our US FDA approved facility in Baddi, Himachal Pradesh.
Consistent Quality
Rigorous quality control at every stage ensures reliable purity and potency across every batch produced.
Global Reach
Trusted by pharmaceutical partners and distributors across 90+ countries worldwide.
Mechanism of Action
Sitagliptin inhibits dipeptidyl peptidase-4 (DPP-4) enzyme resulting in prolonged active incretin levels. Incretin hormones (e.g., glucagon-like peptide-1 [GLP-1] and glucose-dependent insulinotropic polypeptide [GIP]) regulate glucose homeostasis by increasing insulin synthesis and release from pancreatic beta cells and decreasing glucagon secretion from pancreatic alpha cells.
Contact Us
